Stereotactic radiosurgery: a "targeted" therapy for cancer

Area of Science:

• Oncology
• Medical Physics
• Radiotherapy

Background:

• Medical advancements are driven by scientific and technological innovation.
• Targeted cancer therapies have emerged due to recent scientific progress.
• Traditional radiation therapy has evolved with improved planning and delivery systems.

Purpose of the Study:

• To review the progress and controversies surrounding stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT).
• To illustrate the role of stereotactic radiation therapy in the multidisciplinary care of cancer patients.
• To provide an overview of advanced "targeted" radiation treatment options.

Main Methods:

• Literature review of scientific and medical advancements in cancer therapy.
• Analysis of progress and ongoing debates in SRS and SBRT.
• Discussion of the integration of stereotactic radiation techniques into cancer treatment protocols.

Main Results:

• Stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) represent significant advancements in radiation therapy.
• These techniques offer "targeted" treatment options beyond traditional cellular and molecular therapies.
• Ongoing progress and discussions shape the application of SRS and SBRT in clinical practice.

Conclusions:

• Stereotactic radiation therapy, including SRS and SBRT, is a crucial component of modern multidisciplinary cancer care.
• Technological innovations continue to expand the possibilities for targeted cancer treatments.
• Understanding the progress and controversies of SRS and SBRT is essential for optimizing patient outcomes.